CAS NO: | 941678-49-5 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
产品名称: | 鲁索利替尼 |
CAS: | 941678-49-5 |
分子式: | C17H18N6 |
分子量: | 306.37 |
纯度: | ≥98% |
溶解性: | DMSO |
存储: | Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month |
研究领域: | Cancer |
Target: | IC50: 3.3 nM (JAK1), 2.8 nM (JAK2)[1] |
描述: | Ruxolitinib is the first potent, selective JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM in cell-free assays, and has > 130-fold selectivity for JAK1/2 versus JAK3. |